Safety Notices

From time to time notices relating to the safety and/or quality of medicinal products are published by the Health Products Regulatory Authority

These notices are classified under several priority related categories and may relate to human and veterinary medicines, or medical devices.   

The issues covered by these notices will range from quality defect information and medicinal product safety information through to updated information on the appropriate usage of medicines or devices.

Notices are categorised in accordance with their importance at time of publication.

The four notice categories are outlined as follows:

  • Advisory  -  Routine safety information            
  • Warning  -  Urgent safety information
  • Recall  -  Urgent safety information relating to a product recall
  • Publications  -  General safety information provided by the HPRA for publication via 3rd parties e.g. MIMS

The HPRA Drug Safety Newsletter is also published on a regular basis.

Date Title Type
30/04/2007 METHYLPHENIDATE 3rd Party Publications
01/04/2007 Mabthera (Rituximab) - Important Safety Information from Roche as approved by the Irish Medicines Board 01.04.2007 3rd Party Publications
01/04/2007 Ketek (telithromycin) 400mg film coated tablets - Important Safety Information from Sanofi Aventis as approved by the Irish Medicines Board 3rd Party Publications
30/03/2007 BCG Vaccine SSI 3rd Party Publications
29/03/2007 InductOs (dibotermin alfa) - Important Safety Information from Wyeth Pharmaceuticals as approved by the Irish Medicines Board 3rd Party Publications
27/03/2007 Actos (Pioglitazone) - Important Safety Information from Takeda as approved by the Irish Medicines Board 3rd Party Publications
14/03/2007 Integrilin (eptifibatide) - Important Safety Information from GlaxoSmithKline as approved by the Irish Medicines Board 3rd Party Publications
12/03/2007 Flolan (epoprostenol) - Important Safety Information from GlaxoSmithKline as approved by the Irish Medicines Board 3rd Party Publications
12/03/2007 Zyvox (linezolid injection, tablets and oral suspension) - Important Safety Information from Pfizer as approved by the Irish Medicines Board 3rd Party Publications
07/03/2007 Avandia (rosiglitazone maleate) - Important Safety Information from GlaxoSmithKline as approved by the Irish Medicines Board 3rd Party Publications